UPDATE 2-Lilly gets U.S. nod for arthritis drug, sets price well below rivals
June 01, 2018 at 13:58 PM EDT
* Drug priced at $25,000/year, 60 pct lower to AbbVie's Humira
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.